Isoquinolinone potassium channel inhibitors

Details for Australian Patent Application No. 2004276236 (hide)

Owner Merck & Co., Inc.

Inventors Trotter, B. Wesley; Claremon, David A.; Ponticello, Gerald S.; McIntyre, Charles J.; Claiborne, Christopher; Liverton, Nigel

Agent Spruson & Ferguson

Pub. Number AU-B-2004276236

PCT Pub. Number WO2005/030791

Priority 60/505,101 23.09.03 US

Filing date 17 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 24 January 2008

International Classifications

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/47 (2006.01) - Quinolines

C07D 221/02 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 455/04 (2006.01) Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/030791 Priority application(s): WO2005/030791

24 January 2008 Application Accepted

  Published as AU-B-2004276236

22 May 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276237-Quinoline potassium channel inhibitors

2004276234-Methods, devices and compositions for depositing and orienting nanostructures